An impact and cost-effectiveness study of rotavirus vaccination in Mongolia estimated that rotavirus vaccination, from the government perspective, would be highly cost-effective, with a cost per DALY averted of $412 for the low-cost ROTAVAC vaccine produced in India and around $1,000 for the two other available vaccines.
Full Citation:
Lusvan ME, Debellut F, Clark A et al.. 2019. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia. Vaccine. 37(6).
Title of Article: Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
Author(s): Lusvan ME, Debellut F, Clark A et al.
Publication Year: 2019
Publication Name: Vaccine
Publication Volume: 37(6)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/30639458/
DOI (Digital Object Identifier): 10.1016/j.vaccine.2018.12.056
Topics: Economics & Return on Investment
Disease Vaccines: Rotavirus
Countries: Mongolia
WHO Regions: Western Pacific